Obesità: da amplificatore di rischio a malattia cronica

47 DOCUMENTO SIPREC 2022 26. Zhang X, Lerman LO. Obesity and renovascular disease. Am J Physiol Renal Physiol. 2015. 309: F273–9. 27. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998. 31: 409–414. 28. Câmara NOS, Iseki K, Kramer H, Liu Z-H, Sharma K. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol. 2017. 13: 181–190. 29. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008. 118: 1645–1656. 30. Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med. 2010. 3: 335–343. 31. Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med. 2003. 168: 10–48. 32. McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009. 180: 692–700. 33. Mohammad S, Aziz R, Al Mahri S, Malik SS, Haji E, Khan AH, et al. Obesity and COVID-19: what makes obese host so vulnerable? Immun Ageing. 2021. 18: 1. 34. K Y SK, R Bhat PK, Sorake CJ. Double trouble: a pandemic of obesity and COVID-19. The lancet. Gastroenterology & hepatology. 2021. p. 608. 35. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity . 2020. 28: 1195–1199. 36. Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O’Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021. 9: 350–359. 37. Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, et al. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020. 71: 896–897. 38. Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig. 2016. 26: 25–42. 39. Serena C, Keiran N, Ceperuelo-Mallafre V, Ejarque M, Fradera R, Roche K, et al. Obesity and Type 2 Diabetes Alters the Immune Properties of Human Adipose Derived Stem Cells. Stem Cells. 2016. 34: 2559–2573. 40. Higham A, Singh D. Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight. Obesity . 2020. 28: 1586–1589. 41. Gazzaruso C, Paolozzi E, Valenti C, Brocchetta M, Naldani D, Grignani C, et al. Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity. Nutr Metab Cardiovasc Dis. 2020. 30: 1914–1919.

RkJQdWJsaXNoZXIy NDUyNTU=